Charles Cherington Comera Life Sciences Holdings, Inc. (CMRA) insider trading activity

Charles Cherington is > 10% Shareholder of Comera Life Sciences Holdings, Inc.. Currently has a direct ownership of 5.81 Million shares of CMRA, which is worth approximately $0. The most recent transaction as insider was on Sep 11, 2023, when has been sold 2,053,789 shares (Common Stock) at a price of $0.51 per share, resulting in proceeds of $1,047,432. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.81M

0% 3M change

0% 12M change

Total Value Held $0

Charles Cherington Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 11 2023	BUY Open market or private purchase	$1,047,432 $0.51 p/Share	2,053,789 Added 26.1%	5,813,650 Common Stock
Jul 31 2023	BUY Open market or private purchase	$448,899 $0.51 p/Share	880,195 Added 18.97%	3,759,861 Common Stock
Jan 04 2023	BUY Open market or private purchase	$914,188 $1.23 p/Share	743,243 Added 20.52%	2,879,666 Common Stock
Oct 21 2022	BUY Open market or private purchase	$18,589 $1.59 p/Share	11,691 Added 1.77%	649,937 Common Stock
Oct 20 2022	BUY Open market or private purchase	$5,040 $1.52 p/Share	3,316 Added 0.52%	638,246 Common Stock
Oct 17 2022	BUY Open market or private purchase	$25,342 $1.66 p/Share	15,266 Added 2.35%	634,930 Common Stock
Oct 14 2022	BUY Open market or private purchase	$6,805 $1.6 p/Share	4,253 Added 0.68%	619,664 Common Stock
Oct 13 2022	BUY Open market or private purchase	$17,398 $1.66 p/Share	10,481 Added 1.67%	615,411 Common Stock
Sep 29 2022	BUY Open market or private purchase	$33,473 $1.87 p/Share	17,900 Added 2.87%	604,930 Common Stock
Sep 27 2022	BUY Open market or private purchase	$20,280 $1.69 p/Share	12,000 Added 2.0%	587,030 Common Stock

Also insider at

BTX

Brooklyn ImmunoTherapeutics, Inc. Healthcare

> 10% Shareholder